Evemie Schutyser

Amino-terminal truncation of CXCR3 agonists impairs receptor signaling and lymphocyte chemotaxis, while preserving antiangiogenic properties

Paul Proost, Evemie Schutyser, Patricia Menten et al. · Blood · 2001 · 233 citations · Full text

Life Sciences, Immunology, Molecular Biology +17

Identification of Biologically Active Chemokine Isoforms from Ascitic Fluid and Elevated Levels of CCL18/Pulmonary and Activation-regulated Chemokine in Ovarian Carcinoma

Evemie Schutyser, Sofie Struyf, Paul Proost et al. · Journal of Biological Chemistry · 2002 · 208 citations · Full text

Medicine, Cancer Biology, Oncology +17

Citrullination of CXCL8 by peptidylarginine deiminase alters receptor usage, prevents proteolysis, and dampens tissue inflammation

Paul Proost, Tamara Loos, Anneleen Mortier et al. · The Journal of Experimental Medicine · 2008 · 175 citations · Full text

Life Sciences, Biochemistry, Immunology +17

Cleavage by CD26/dipeptidyl peptidase IV converts the chemokine LD78β into a most efficient monocyte attractant and CCR1 agonist

Paul Proost, Patricia Menten, Sofie Struyf et al. · Blood · 2000 · 154 citations

Life Sciences, Biochemistry, Molecular Biology +13

Proteolytic processing of CXCL11 by CD13/aminopeptidase N impairs CXCR3 and CXCR7 binding and signaling and reduces lymphocyte and endothelial cell migration

Paul Proost, Anneleen Mortier, Tamara Loos et al. · Blood · 2007 · 133 citations · Full text

Life Sciences, Immunology, Molecular Biology +17